SKVARKA JAN purchased 67.0% of their position (60K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $103.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/4/2025ACC: 0001725160-25-000030
Director
Since Sep 2022
+60K
Net shares
Net buyer
$103.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
$1.72
Trade value
$103.45K
% of position
67.0%
1/31/2025
89.55K→149.55K
Total
Net shares
+60K
Net value
$103.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | P · Purchase | +60K | $1.72 | $103.45K | 67.0% | 89.55K | 149.55K |
| Total | +60K | $103.45K | ||||||
Derivative Transactions0
No derivative transactions reported